Myocardial fibrosis in mice with overexpression of human blood coagulation factor IX
Open Access
- 1 March 2003
- journal article
- Published by American Society of Hematology in Blood
- Vol. 101 (5) , 1871-1873
- https://doi.org/10.1182/blood-2002-05-1581
Abstract
Elevated circulatory levels of many blood coagulation factors are known to be a risk factor for deep vein thrombosis in humans. Here we report the first direct demonstration of a close association between elevated circulatory factor IX levels in mice with thrombosis as well as myocardial fibrosis. Transgenic mice overexpressing human factor IX at persistently high levels died at much younger ages than their cohorts expressing lower levels, or nontransgenic control animals. The median survival age of animals was inversely related to the circulatory levels of human factor IX. Prematurely dying animals had focal fibrotic lesions predominantly present in the left ventricular myocardium, and vasculatures in these lesions showed fibrin deposition. Thromboemboli were also present in other organs, including lung and brain. These observations support the hypothesis that persistently high circulatory levels of factor IX are a risk factor not only for thrombosis and/or thromboembolism, but also for myocardial fibrosis mimicking human myocardial infarction.Keywords
This publication has 13 references indexed in Scilit:
- Genetic Mechanisms of Age Regulation of Protein C and Blood CoagulationJournal of Biological Chemistry, 2002
- Hemostatic Risk Factors and Arterial Thrombotic DiseaseThrombosis and Haemostasis, 2001
- Activation of Clotting Factors XI and IX in Patients With Acute Myocardial InfarctionArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- High Plasma Levels of Factor VIII and the Risk of Recurrent Venous ThromboembolismNew England Journal of Medicine, 2000
- Blood coagulationThe Lancet, 2000
- High Levels of Coagulation Factor XI as a Risk Factor for Venous ThrombosisNew England Journal of Medicine, 2000
- Genetic Mechanisms of Age Regulation of Human Blood Coagulation Factor IXScience, 1999
- A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state.Journal of Clinical Investigation, 1998
- Monoclonal Antibodies to a Synthetic Fibrin-Like Peptide Bind to Human Fibrin But Not FibrinogenScience, 1983
- The use of mallory's phosphotungstic acid-hematoxilin (PTAH) stain in renal pathologyPathology - Research and Practice, 1982